Highlights China Meheco Group Co., Ltd.

Equities

600056

CNE000000Q29

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
11.38 ^CNY	+3.64%		+3.36%	+1.88%

Apr. 26	China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 20	Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection	Feb. 20	MT
Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation	Feb. 20	MT
Meheco's Unit Gets Nod to Market Peramivir Injection; Shares Down 4%	Feb. 05	MT
Meheco Unit's Antibiotic Passes Regulatory Evaluation in China	Jan. 24	MT
China Meheco Group Co., Ltd. agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million.	Dec. 22	CI
Genertec Universal, Parent Form 2 Billion Yuan Fund	Dec. 22	MT
China Meheco Group's Drugs Chosen for China's Centralized Drug Procurement	Nov. 08	MT
China Meheco Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
China Meheco Group Unit's Norfloxacin Capsules Passes Drug Regulator's Evaluation	23-10-13	MT
China Meheco Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
China Medicine Health Industry Gets Registration Certificate for Sitafloxacin Tablets	23-06-16	MT
New rules to dampen Chinese interest to list in Europe, say bankers	23-05-22	RE
China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
China Meheco Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
China Medicine Health Industry Unit Gets Regulatory Nod for Gastrointestinal Bleeding Drug	23-03-08	MT
China Medicine Health Industry Unit's Injection Passes Regulator's Consistency Evaluation	23-03-06	MT
Meheco Unit's Anti-Bacterial Injection Passes Regulator's Evaluation	23-02-03	MT
Meheco Says Pfizer Distribution Deal Won’t Have Significant Impact on Performance; Shares Plunge 9%	22-12-21	MT
China Meheco to Distribute Pfizer’s COVID-19 Drug in China; Shares Rally 10%	22-12-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights China Meheco Group Co., Ltd.

Equities

600056

CNE000000Q29

Highlights

Filters